{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:12:32Z","timestamp":1778073152425,"version":"3.51.4"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>IgA nephropathy (IgAN), a condition posing a significant threat to public health, currently lacks a specific treatment protocol. Research has underscored the potential benefits of traditional Chinese medicine (TCM) for treating IgAN. Nevertheless, the effectiveness of various intervention strategies, such as combining TCM with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs), lacks a comprehensive systematic comparison. Therefore, this study aimed to conduct a network meta-analysis to assess the clinical efficacy of ACEIs, ARBs, TCM, and their combinations in treating IgAN to offer novel insights and approaches for the clinical management of IgAN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A systematic review conducted until November 2023 included relevant literature from databases such as PubMed, Embase, Cochrane, Web of Science, Scopus, CNKI, and Wanfang. Two independent researchers screened and assessed the data for quality. Network and traditional meta-analyses were performed using Stata 18.0 and RevMan 5.3 software, respectively. Outcome measures included 24-h urinary protein quantification (24 hpro), estimated glomerular filtration rate (eGFR), serum creatinine (Scr), blood urea nitrogen (BUN), and adverse event incidence rates (ADRs). Forest plots, cumulative ranking probability curves (SUCRA), and funnel plots generated using Stata 18.0 facilitated a comprehensive analysis of intervention strategies\u2019 efficacy and safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>This study included 72 randomized controlled trials, seven interventions, and 7,030 patients. Comparative analysis revealed that ACEI + TCM, ARB + TCM combination therapy, and TCM monotherapy significantly reduced the levels of 24 hpro, eGFR, Scr, and BUN compared to other treatment modalities (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). TCM monotherapy demonstrated the most favorable efficacy in reducing eGFR levels (SUCRAs: 78%), whereas the combination of ARB + TCM reduced Scr, 24 hpro, and BUN levels (SUCRAs: 85.7%, 95.2%, and 87.6%, respectively), suggesting that ARB + TCM may represent the optimal intervention strategy. No statistically significant differences were observed among the various treatment strategies in terms of ADR (<jats:italic>p<\/jats:italic> &amp;gt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The combination of ACEI or ARB with TCM demonstrated superior efficacy compared to ACEI\/ARB monotherapy in the treatment of IgAN without any significant ADRs. Therefore, combination therapies can be used to enhance therapeutic outcomes based on individual patient circumstances, highlighting the use of TCM as a widely applicable approach in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration:<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>, identifier CRD42023476674.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1374377","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T05:13:39Z","timestamp":1710998019000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of traditional Chinese medicine versus angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and their combinations in the treatment of IgA nephropathy: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Sijia","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"B1","first-page":"3726","article-title":"Effect of Tripterygium wilfordii polyglycosides combined with telmisartan in the treatment of patients with primary IgA nephropathy with moderate proteinuria","volume":"27","author":"Cai","year":"2018","journal-title":"Henan Med. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.13288\/j.11-2166\/r.2021.11.011","article-title":"Effect of modified Huangqi Chifeng decoction on proteinuria and urinary podocyte-related protein expression in patients with IgA nephropathy of qi deficiency, blood stasis and pathogenic wind and heat toxin syndrome","volume":"62","author":"Chang","year":"","journal-title":"J. Tradit. Chin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/s41467-021-21517-5","article-title":"Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates","volume":"12","author":"Chang","year":"","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3969\/j.issn.2095-7246.2022.04.006","article-title":"Clinical effect of Oiteng Xiaozhuo granule in treatment of lgA nephropathy withSpleen-kidney deficiency and blood stasis","volume":"41","author":"Chen","year":"2022","journal-title":"J. Anhui Univ. China Med."},{"key":"B5","first-page":"101","article-title":"Multicentered randomized controlled clinical trial on patients with IgA nephropathy of Qi yin deficiency syndrome type","volume":"27","author":"Chen","year":"2007","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"B6","first-page":"1061","article-title":"Prospective multi-centered randomized and controlled trial on effect of Shenle capsule in treating patients with IgA nephropathy of Fei Pi Qi deficiency syndrome","volume":"26","author":"Chen","year":"2006","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/ndt\/gfy338","article-title":"Towards a personalized treatment for IgA nephropathy considering pathology and pathogenesis","volume":"34","author":"Coppo","year":"2019","journal-title":"Nephrol. Dial. Transpl."},{"key":"B8","unstructured":"Clinical efficacy on treating IgA nephropathywith Zini-Shenyan decoction\n            DuanX. F.\n          FujianFujian University of Traditional Chinese Medicine2011"},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.13457\/j.cnki.jncm.2014.05.027","article-title":"Clinical observation of modified Erzhi pill in the treatment of IgA nephropathy","volume":"46","author":"Duan","year":"2014","journal-title":"New J. Tradit. Chin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1007\/s11356-019-07232-1","article-title":"Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat","volume":"27","author":"Eftekhari","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/ASN.0000000000000242","article-title":"Treatment of IgA nephropathy: a rapidly evolving field","volume":"35","author":"El Karoui","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.kint.2022.04.018","article-title":"Assessing prognosis in IgA nephropathy","volume":"102","author":"Floege","year":"2022","journal-title":"Kidney Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jep.2011.08.077","article-title":"Therapeutic mechanisms of Tongmai Dasheng Tablet on Tripterygium glycosides induced rat model for premature ovarian failure","volume":"139","author":"Fu","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2152694","DOI":"10.1080\/0886022X.2022.2152694","article-title":"Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors","volume":"45","author":"Gadola","year":"2023","journal-title":"Ren. Fail."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.13193\/j.issn.1673-7717.2019.08.042","article-title":"Clinical efficacy of Qiangshen Quyu Tongluo prescription and olmesartan Medoxomi I in treatment of kidney deficiency and blood stasis in Collatarels type IgA nephropathy","volume":"37","author":"Gan","year":"2019","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"B16","unstructured":"Clinical efficacy on treating IgA nephropathywith Shenmao-Shiwei decoction\n            GaoS.\n          FujianFujian University of Traditional Chinese Medicine2009"},{"key":"B17","first-page":"36","article-title":"Clinical observation on treatment of lgA nephropathy with Huobahuagen Tablets and irbesartan","volume":"3","author":"Guan","year":"2005","journal-title":"Chin. Integr. Med."},{"key":"B18","first-page":"841","article-title":"Effect of treatment of non-nephrotic syndrome IgA nephropathy with Shenyanning","volume":"30","author":"Guo","year":"2010","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.13638\/j.issn.1671-4040.2023.07.006","article-title":"Effect and mechanism of Huozhuohuagen tablets combined with losartan potassium tablets in the treatment of IgA nephropathy","volume":"23","author":"Guo","year":"2023","journal-title":"Pract. Clin. J. Integr. Tradit. Chin. West. Med."},{"key":"B20","unstructured":"Clinical study of Zishen Huoxue decoction in the treatment ofIgA nephropathy with liver-kidney yin deficiency and blood stasis\n            GuoS. F.\n          YunnanYunnan University of Traditional Chinese Medicine2019"},{"key":"B21","unstructured":"Observation on the curative effect of Qi-yin nourishing method on IgA nephropathy with deficiency of Qi and Yin\n            HanC. E.\n          ChengduChengdu University of Traditional Chinese Medicine2012"},{"key":"B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3969\/j.issn.1002-2619.2016.01.013","article-title":"Clinical observation of ginseng Guipi pill combined with benazepril in the treatment of 50 cases of IgA nephropathy","volume":"38","author":"Han","year":"2016","journal-title":"Hebei J. Tradit. Chin. Med."},{"key":"B23","first-page":"998","article-title":"Clinical study of Huangkui capsule combined with benazepril in the treatment of primary IgA nephropathy","volume":"11","author":"Han","year":"2010","journal-title":"Chin. J. Integr. Tradit. West. Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1291\/hypres.27.963","article-title":"Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin A nephropathy","volume":"27","author":"Horita","year":"2004","journal-title":"Hypertens. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1440-1797.2006.00665.x","article-title":"Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy","volume":"11","author":"Horita","year":"2006","journal-title":"Nephrol. Carlt."},{"key":"B26","first-page":"89","article-title":"Clinical study of candesartan combined with benazepril hydrochloride in the treatment of IgA nephropathy proteinuria","volume":"8","author":"Hou","year":"2009","journal-title":"J. Clin. Exp. Med."},{"key":"B27","first-page":"11","article-title":"Clinical observation of compound Xiancao capsule in the treatment of latent IgA nephropathy","volume":"11","author":"Huang","year":"","journal-title":"J. Guangxi Univ. China Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.16367\/j.issn.1003-5028.2012.12.093","article-title":"Gastritis Kangfu tablet combined with fosinopril in the treatment of 25 cases of IgA nephropathy","volume":"32","author":"Huang","year":"2012","journal-title":"Henan. J. Tradit. Chin. Med."},{"key":"B29","unstructured":"Clinical efficacy on treating IgA nephropathywith oilian maogen decoction\n            HuangL. L.\n          FujianFujian University of Traditional Chinese Medicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3969\/j.issn.1002-1108.2011.01.15","article-title":"Clinical observation of Bailing capsule combined with benazepril in the treatment of 33 cases of IgA nephropathy","volume":"33","author":"Huang","year":"2011","journal-title":"J. Guizhou Univ. J. Tradit. Chin. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e11661","DOI":"10.7717\/peerj.11661","article-title":"Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs","volume":"9","author":"Huo","year":"2021","journal-title":"PeerJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1681\/ASN.2018101017","article-title":"Mortality in IgA nephropathy: a nationwide population-based cohort study","volume":"30","author":"Jarrick","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B34","first-page":"8","article-title":"Clinical study on self-design ZiCao DiHuang DiYuTang in treating IgA nephropathy of YinD efficiency type and dual defficiency type of Qi and Yin: a report of 33 cases","volume":"25","author":"Jia","year":"2012","journal-title":"West. J. Tradit. Chin. Med."},{"key":"B35","first-page":"311","article-title":"Study of urinary IL-6 and serum secretory IgA in IgA nephropathy treated with purging kidney and cooling blood","volume":"19","author":"Li","year":"2018","journal-title":"Chin. J. Integr. Tradit. West. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.13457\/j.cnki.jncm.2023.06.015","article-title":"Clinical study on Ziyin Yishen prescription combined with telmisartan for primary IgA nephropathy","volume":"55","author":"Li","year":"2023","journal-title":"New J. Tradit. Chin. Med."},{"key":"B37","first-page":"74","article-title":"Clinical study of Huangkui Capsule combined with olmesartan in the treatment of IgA nephropathy with mild to moderate proteinuria","volume":"9","author":"Li","year":"2012","journal-title":"Chin. Her."},{"key":"B38","doi-asserted-by":"publisher","first-page":"153231","DOI":"10.1016\/j.phymed.2020.153231","article-title":"Efficacy and safety of Abelmoschus manihot for IgA nephropathy: a multicenter randomized clinical trial","volume":"76","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.ajkd.2006.01.017","article-title":"Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study","volume":"47","author":"Li","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3969\/j.issn.1000-7369.2017.09.018","article-title":"Clinical observation of Huangkui capsule combined with losartan potassium in the treatment of IgA nephropathy","volume":"38","author":"Liang","year":"2017","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.13424\/j.cnki.mtcm.2010.06.023","article-title":"Compound Shenfu tablets in the treatment of 32 cases of IgA nephropathy","volume":"30","author":"Liu","year":"2010","journal-title":"Mod. Tradit. Chin. Med."},{"key":"B42","first-page":"1805","article-title":"Therapeutic efficacy of fleabane combined with fosinopril for IgA nephropathy","author":"Liu","year":"","journal-title":"J. Air Force Med. Univ."},{"key":"B43","first-page":"437","article-title":"Comparison of therapeutic effect of higher-dose valsatan combined with higher dose of lotensin for IgA nephropathy","volume":"28","author":"Liu","year":"","journal-title":"J. Xi\u2019an Jiaot. Univ. Med. Sci."},{"key":"B44","unstructured":"Clinical observation on the effect of modified Shenqi Dihuang decoction on proteinuria and hematuria of IgA nephropathy with deficiency of qi and yin\n            LongP.\n          GuangxiGuangxi University of Traditional Chinese Medicine2021"},{"key":"B45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.19844\/j.cnki.1672-397X.2021.02.015","article-title":"Shaoyang decoction combined with irbesartan tablets in the treatment of IgA nephropathy of Shaoyang syndrome Clinical study of 30 cases","volume":"53","author":"Lu","year":"2021","journal-title":"Jiangsu J. Tradit. Chin. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3969\/j.issn.1000-8535.2023.02.009","article-title":"Effects of Bailing capsules assisting valsartan in the treatment of IgA nephropathy and its influence on renal function, Th1\/Th2 drift, urine PCX and B7-1 levels","volume":"54","author":"Luo","year":"2023","journal-title":"Guangzhou Med. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"key":"B97","doi-asserted-by":"publisher","first-page":"154913","DOI":"10.1016\/j.phymed.2023.154913","article-title":"Effects and mechanisms of Chinese herbal medicine on IgA nephropathy","volume":"117","author":"Ma","year":"2023","journal-title":"Phytomedicine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"eabm8783","DOI":"10.1126\/sciadv.abm8783","article-title":"Identification and characterization of circulating immune complexes in IgA nephropathy","volume":"8","author":"Matsumoto","year":"2022","journal-title":"Sci. Adv."},{"key":"B49","first-page":"131","article-title":"Clinical research of yiqi yangshen decoction curing qiyinliangxu of IgA nephropathy","volume":"16","author":"Meng","year":"2015","journal-title":"Chin. J. Integr. Tradit. West. Nephrol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.amjhyper.2007.06.003","article-title":"Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy","volume":"20","author":"Nakamura","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"B51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3969\/j.issn.1008-8849.2022.02.015","article-title":"Clinical observation of Yiqi Huoxue Tongluo recipe in the treatment of IgA nephropathy of qi deficiency and blood stasis type","volume":"31","author":"Pan","year":"2022","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.13193\/j.issn.1673-7717.2017.12.038","article-title":"Clinical observation of bushen tiaogan huayu method in treatment of IgA nephropathy","volume":"35","author":"Pan","year":"2017","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e33123","DOI":"10.1097\/MD.0000000000033123","article-title":"Clinical efficacy of supplementing qi dispelling wind and activating blood circulation method in the treatment of IgA nephropathy: a meta-analysis","volume":"102","author":"Pan","year":"2023","journal-title":"Med. (Baltim.)."},{"key":"B54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"IgA nephropathy: an interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/00365590410015687","article-title":"Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis","volume":"38","author":"Renke","year":"2004","journal-title":"Scand. J. Urol. Nephrol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biopha.2016.12.105","article-title":"Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney","volume":"87","author":"Samarghandian","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00508-023-02257-6","article-title":"Diagnosis and treatment of IgA nephropathy-2023","volume":"135","author":"Schimpf","year":"2023","journal-title":"Wien. Klin. Wochenschr"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2310\/JIM.0b013e31826741d2","article-title":"Renal protection of losartan 50 mg in normotensive Chinese patients with nondiabetic chronic kidney disease","volume":"60","author":"Shen","year":"2012","journal-title":"J. Investig. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00467-018-4099-8","article-title":"Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study)","volume":"34","author":"Shima","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.16386\/j.cjpccd.issn.1004-6194.2014.05.043","article-title":"Effect of Huangkui capsule combined with irbesartan in the treatment of IgA nephropathy","volume":"22","author":"Su","year":"2014","journal-title":"Chin. J. Prev. Control. Chronic Non-Commun. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.13288\/j.11-2166\/r.2019.22.010","article-title":"Treatment of severe IgA nephropathy patients with liver and kidney yin deficiency syndrome by traditional Chinese medicine syndrome differentiation Combinated with losartan potassium: a prospective and multicentered clinical study","volume":"60","author":"Wang","year":"2019","journal-title":"J. Tradit. Chin. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.13288\/j.11-2166\/r.2019.22.010","article-title":"TCM syndrome differentiation-based treatment combined with losartan potassium in treating severe IgA nephropathy with yin deficiency of liver and kidney syndrome:A multicenter randomized controlled trial","volume":"35","author":"Wang","year":"","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"B64","first-page":"18","article-title":"Therapeutic effect of Huangkui Capsule on IgA nephropathy with damp-heat syndrome","volume":"32","author":"Wang","year":"","journal-title":"Chin. Tradit. Pat. Med."},{"key":"B65","first-page":"309","article-title":"Treatment outcome of TCM and WM therapy on IgA nephropathy with Chaiqin decoction","volume":"21","author":"Wang","year":"","journal-title":"Chin. J. Integr. Tradit. West. Nephrol."},{"key":"B66","unstructured":"Effects of modified Huangqi Chifeng decoction on proteinuria and urinary TGF-\u03b21 and MCP-1 in patients with IgA nephropathy\n            WangR. M.\n          ChinaChina Academy of Chinese Medical Sciences2021"},{"key":"B67","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.26355\/eurrev_202212_30547","article-title":"A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy","volume":"26","author":"Wang","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.14010\/j.cnki.wjyx.2014.10.016","article-title":"Efficacy of Zhengqiang Fengtongning tablets in the treatment of IgA nephropathy with moderate amount of proteinuria","volume":"25","author":"Wang","year":"2014","journal-title":"Med. J. Chin. PAPF."},{"key":"B69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2478\/jtim-2021-0021","article-title":"Traditional Chinese medicine in treating IgA nephropathy: from basic science to clinical research","volume":"9","author":"Wang","year":"","journal-title":"J. Transl. Int. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"132","DOI":"10.15912\/j.cnki.gocm.2020.29.063","article-title":"Clinical efficacy of Tripterygium Wilfordii polyglycoside combined with omesartan in the treatment of patients with primary IgA nephropathy","volume":"18","author":"Wang","year":"","journal-title":"Guide Chin. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.16368\/j.issn.1674-8999.2018.07.316","article-title":"Yishen Qufeng Chushi granule combined with losartan potassium in treatment of IgA nephropathy","volume":"33","author":"Wang","year":"2018","journal-title":"China J. China Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.11842\/wst.20201210008","article-title":"Effect of Qiyu Qinghua decoction combined with losartan potassium tablets on TLR4 and inflammatory cytokine expression in IgA nephropathy","volume":"23","author":"Wang","year":"","journal-title":"Mod. Tradit. Chin. Med. Mater. medica-world Sci. Tech."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3969\/j.issn.1008-0805.2020.08.041","article-title":"To investigate the clinical efficacy of QishingQinghua decoction in the treatment of IgA nephropathy with spleen-kidney Yang deficiency syndrome and its effect on oxidative stress","volume":"31","author":"Wang","year":"","journal-title":"Lishizhen Med. Mater. Med. Res."},{"key":"B74","first-page":"19","article-title":"Observation on the therapeutic effect of valsartan combined fosinopril in treating IgA Nephropathy","volume":"7","author":"Wang","year":"","journal-title":"Med. Innov. China."},{"key":"B75","first-page":"28","article-title":"Clinical study of Tongluo-Ningxue decoction in the treatment of 30 cases of IgA nephropathy of kidney deficiency and blood stasis type","volume":"49","author":"Wei","year":"2017","journal-title":"Jiangsu J. Tradit. Chin. Med."},{"key":"B76","first-page":"187","article-title":"Observation of Tripterygium wilfordii polyglycosides combined with irbesartan in the treatment of IgA nephropathy","volume":"35","author":"Wei","year":"2019","journal-title":"J. Pract. Tradit. Chin. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/ndt\/gfad101","article-title":"The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis","volume":"38","author":"Whitlock","year":"2023","journal-title":"Nephrol. Dial. Transpl."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s11255-021-03094-0","article-title":"New insights into pathogenesis of IgA nephropathy","volume":"54","author":"Xia","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"756","DOI":"10.13935\/j.cnki.sjzx.140725","article-title":"Efficacy observation of IgA nephropathy treated with Tripterygium glycosides tablets and telmisartan in the middle and aged patients","volume":"9","author":"Xiang","year":"2014","journal-title":"Integr. Tradit. West. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.13457\/j.cnki.jncm.2009.10.014","article-title":"Clinical trial of Shenyankang decoction for the treatment of lgA nephropathy","volume":"41","author":"Xiang","year":"2009","journal-title":"New J. Tradit. Chin. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.16305\/j.1007-1334.2009.10.001","article-title":"Clinical research on \u201cNianmoDecoction\u201d in treating IgA nephropathy","volume":"43","author":"Xu","year":"2009","journal-title":"Shanghai J. Tradit. Chin. Med."},{"key":"B83","first-page":"3065","article-title":"Efficacy analysis of Tripterygium wilfordii polyglucoside combined with benazepril in the treatment of primary IgA nephropathy patients with moderate proteinuria","volume":"31","author":"Xu","year":"2020","journal-title":"Mod. Diagn. Treat."},{"key":"B84","unstructured":"Observation of clinical efficacy on IgA Nephropathy treated by the way of Benefiting Qi, nourishing Yin and promoting blood circulation\n            XueS. L.\n          FujianFujian University of Traditional Chinese Medicine2012"},{"key":"B85","first-page":"69","article-title":"Efficacy of benazepril hydrochloride, dipyridamole combined with Huangkui capsule in the treatment of 21 cases of IgA nephropathy","volume":"50","author":"Yang","year":"2010","journal-title":"J. Nanchang Univ. Med. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"253","DOI":"10.16295\/j.cnki.0257-358x.2011.04.035","article-title":"32 cases of IgA nephropathy were treated with integrated traditional Chinese and western medicine","volume":"30","author":"Yao","year":"2011","journal-title":"Shandong J. Tradit. Chin. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1267924","DOI":"10.3389\/fphar.2023.1267924","article-title":"Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.16040\/j.cnki.cn15-1101.2016.15.004","article-title":"Clinical observation of replenishing qi and nourishing Yin in the treatment of hematuria dominant IgA nephropathy","volume":"35","author":"Zhang","year":"2016","journal-title":"Inn. Mong. J. Tradit. Chin. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/j.ajkd.2014.01.431","article-title":"Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial","volume":"64","author":"Zhang","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3969\/j.issn.1673-7202.2019.05.003","article-title":"Observing clinical effects of treatment of liver and kidney in treatment of IgA nephropathy at different time points","volume":"14","author":"Zhang","year":"","journal-title":"World Chin. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3969\/j.issn.1673-7202.2019.05.004","article-title":"Immune mechanism of inhibiting renal fibrosis in IgA nephropathy by integrating traditional Chinese and western medicine optimized treatment programs","volume":"14","author":"Zhang","year":"","journal-title":"World Chin. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"558","DOI":"10.13463\/j.cnki.cczyy.2021.03.023","article-title":"Clinical study of Shenfukang \u2161 capsules in the treatment of IgA nephropathy with renal tubulointerstitial fibrosis","volume":"37","author":"Zhao","year":"","journal-title":"J. Chang. Univ. China Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"638611","DOI":"10.3389\/fphar.2021.638611","article-title":"Efficacy and safety of angiotensin-converting enzyme inhibitor in combination with angiotensin-receptor blocker in chronic kidney disease based on dose: a systematic review and meta-analysis","volume":"12","author":"Zhao","year":"","journal-title":"Front. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"268","DOI":"10.16367\/j.issn.1003-5028.2022.02.0058","article-title":"Observation of therapeutic effect of Zhiwei Rehmannia decoction on IgA nephropathy with syndrome of kidney deficiency with effulgent fire","volume":"42","author":"Zhao","year":"2022","journal-title":"Henan. J. Tradit. Chin. Med."},{"key":"B95","unstructured":"Clinical observation of sinomenine in the treatment of IgA nephropathy of dampness and blood stasis\n            ZhaoT.\n          HubeiHubei University of Traditional Chinese Medicine2015"},{"key":"B96","first-page":"34","article-title":"Clinical study of Tripterygium Wilfordii\u2019s treatment effect on IgA nephropathy","volume":"48","author":"Zhou","year":"2010","journal-title":"China Mod. doct."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1374377\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T05:14:58Z","timestamp":1710998098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1374377\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":97,"alternative-id":["10.3389\/fphar.2024.1374377"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1374377","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"article-number":"1374377"}}